[go: up one dir, main page]

AU2003904627A0 - Pharmaceutical Formulation - Google Patents

Pharmaceutical Formulation

Info

Publication number
AU2003904627A0
AU2003904627A0 AU2003904627A AU2003904627A AU2003904627A0 AU 2003904627 A0 AU2003904627 A0 AU 2003904627A0 AU 2003904627 A AU2003904627 A AU 2003904627A AU 2003904627 A AU2003904627 A AU 2003904627A AU 2003904627 A0 AU2003904627 A0 AU 2003904627A0
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003904627A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma Pty Ltd
Original Assignee
Mayne Pharma Pty Ltd
Filing date
Publication date
Application filed by Mayne Pharma Pty Ltd filed Critical Mayne Pharma Pty Ltd
Publication of AU2003904627A0 publication Critical patent/AU2003904627A0/en
Priority to NZ545591A priority Critical patent/NZ545591A/en
Priority to EP04761205A priority patent/EP1680103A4/en
Priority to JP2006524178A priority patent/JP2007504098A/en
Priority to GB0718274A priority patent/GB2441445B/en
Priority to CN2010105437134A priority patent/CN102048723A/en
Priority to PCT/AU2004/001168 priority patent/WO2005020980A1/en
Priority to AU2004267877A priority patent/AU2004267877A1/en
Priority to DE112004001563T priority patent/DE112004001563T5/en
Priority to CA002537170A priority patent/CA2537170A1/en
Priority to CNA2004800320201A priority patent/CN101022790A/en
Priority to US10/927,279 priority patent/US20050090544A1/en
Priority to GB0606187A priority patent/GB2421911A/en
Priority to EP10006355A priority patent/EP2243480A1/en
Priority to CN200910212102A priority patent/CN101703467A/en
Priority to US11/363,542 priority patent/US20060264501A1/en
Priority to NO20061417A priority patent/NO20061417L/en
Priority to US11/627,648 priority patent/US20070155833A1/en
Priority to JP2008120644A priority patent/JP2008201804A/en
Priority to HK08106611.8A priority patent/HK1111894B/en
Priority to US12/581,514 priority patent/US20100063145A1/en
Priority to US12/581,624 priority patent/US20100035982A1/en
Priority to JP2012003953A priority patent/JP2012072191A/en
Priority to JP2014000261A priority patent/JP2014080426A/en
Priority to JP2015139485A priority patent/JP6078593B6/en
Abandoned legal-status Critical Current

Links

AU2003904627A 2003-08-28 2003-08-28 Pharmaceutical Formulation Abandoned AU2003904627A0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
CN200910212102A CN101703467A (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
US10/927,279 US20050090544A1 (en) 2003-08-28 2004-08-27 Oxaliplatin formulations
EP10006355A EP2243480A1 (en) 2003-08-28 2004-08-27 Pharmaceutical formulations comprising oxaliplatin and an acid.
JP2006524178A JP2007504098A (en) 2003-08-28 2004-08-27 Oxaliplatin formulation containing acid
GB0718274A GB2441445B (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulation
CN2010105437134A CN102048723A (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
PCT/AU2004/001168 WO2005020980A1 (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
AU2004267877A AU2004267877A1 (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
DE112004001563T DE112004001563T5 (en) 2003-08-28 2004-08-27 Acid-containing oxaliplatin formulations
CA002537170A CA2537170A1 (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
EP04761205A EP1680103A4 (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
NZ545591A NZ545591A (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
GB0606187A GB2421911A (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
CNA2004800320201A CN101022790A (en) 2003-08-28 2004-08-27 Oxaliplatin preparations containing acid
US11/363,542 US20060264501A1 (en) 2003-08-28 2006-02-28 Acid containing oxaliplatin formulations
NO20061417A NO20061417L (en) 2003-08-28 2006-03-28 Acid-containing oxaliplatin formulations
US11/627,648 US20070155833A1 (en) 2003-08-28 2007-01-26 Oxaliplatin formulations
JP2008120644A JP2008201804A (en) 2003-08-28 2008-05-02 Acid-containing oxaliplatin preparation
HK08106611.8A HK1111894B (en) 2003-08-28 2008-06-16 Acid containing oxaliplatin formulations
US12/581,624 US20100035982A1 (en) 2003-08-28 2009-10-19 Oxaliplatin formulations
US12/581,514 US20100063145A1 (en) 2003-08-28 2009-10-19 Acid containing oxaliplatin formulations
JP2012003953A JP2012072191A (en) 2003-08-28 2012-01-12 Acid containing oxaliplatin formulation
JP2014000261A JP2014080426A (en) 2003-08-28 2014-01-06 Acid-containing oxaliplatin formulations
JP2015139485A JP6078593B6 (en) 2003-08-28 2015-07-13 Oxaliplatin formulation containing acid

Publications (1)

Publication Number Publication Date
AU2003904627A0 true AU2003904627A0 (en) 2003-09-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP2289512B8 (en) Pharmaceutical foam
AU2003291103A1 (en) Pharmaceutical composition
AU2003901813A0 (en) Pharmaceutical derivatives
AU2002257582A1 (en) Pharmaceutical formulation
AU2003250372A1 (en) Pharmaceutical composition
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
HUP0303948A2 (en) Solid orally-dispersible pharmaceutical formulation
AU2003226487A1 (en) Formulation
GB0316206D0 (en) Pharmaceutical formulation
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003238900A1 (en) Pharmaceutical formulation
AU2003904627A0 (en) Pharmaceutical Formulation
AUPS188302A0 (en) Pharmaceutical composition
GB0310881D0 (en) Pharmaceutical formulation
AU2002950788A0 (en) Pharmaceutical formulation
HK1093421A (en) Pharmaceutical formulations
AU2004902190A0 (en) Pharmaceutical Formulation
GB0302435D0 (en) Pharmaceutical formulation
HK1089377A (en) Pharmaceutical composition
HK1088245A (en) Pharmaceutical composition
AU2003902322A0 (en) Pharmaceutical composition
HK1092702A (en) Pharmaceutical compositions
HK1092712A (en) Pharmaceutical compositions